Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: November 28, 2023 Report Code: GDME1659EPD-ST

Select Item

Multiparameter Patient Monitoring Pipeline Market Report Overview

Multiparameter patient monitoring includes devices used for continuous monitoring of physiological and vital parameters such as temperature, blood pressure (BP), oxygen saturation in blood (SpO2), respiration rate (RR), and capnography (CO2) in patients continuously. These types of monitors are used in emergency settings, operation theatres (OT), intensive care units (ICU), and physician’s clinics.

The multiparameter patient monitoring pipeline market research report provides comprehensive information about the Multiparameter patient monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Vital Sign Monitors

·        Ambulatory Monitors

·        Critical Care Monitors

·        Low Acuity Monitors
Key Territories ·        The US

·        Europe

·        Israel

·        Canada

·        China
Key Regulatory Paths ·        510(k)

·        CE

·        ICAC

·        NMPA

·        MDL
Leading Companies ·        19Labs Inc

·        Actuated Medical Inc

·        AquilX Inc

·        Baxter International Inc

·        Bertec Corp
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Multiparameter Patient Monitoring Pipeline Market by Segments

Some of the key segments in the multiparameter patient monitoring pipeline market are vital sign monitors, ambulatory monitors, critical care monitors, and low acuity monitors, among others. As of November 2023, the vital sign monitors segment led the market with the highest number of pipeline products. Vital sign monitors are used to measure and record the basic vital signs such as pulse rate, temperature, and respiratory rate of an individual. These types of monitors are mostly used in small healthcare settings, physician offices, clinics, etc.

Multiparameter Patient Monitoring Pipeline Market Analysis by Segments, 2023 (%)

Multiparameter Patient Monitoring Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Multiparameter Patient Monitoring Pipeline Market
Download a Free Report Sample

Multiparameter Patient Monitoring Pipeline Market Segmentation by Territories

Some of the key territories in the multiparameter patient monitoring market are the US, Europe, Israel, Canada, and China among others. As of November 2023, the US has the highest number of pipeline products.

Multiparameter Patient Monitoring Pipeline Market Analysis by Territories, 2023 (%)

Multiparameter Patient Monitoring Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Multiparameter Patient Monitoring Pipeline Market

Download a Free Report Sample

Multiparameter Patient Monitoring Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the multiparameter patient monitoring pipeline market are 510(k), CE, ICAC, NMPA, and MDL among others. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Multiparameter Patient Monitoring Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Multiparameter Patient Monitoring Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Multiparameter Patient Monitoring Pipeline Market
Download a Free Report Sample

Multiparameter Patient Monitoring Pipeline Market – Competitive Landscape

Some of the key companies in the multiparameter patient monitoring pipeline market are 19Labs Inc., Actuated Medical Inc., AquilX Inc., Baxter International Inc., and Bertec Corp. among others.

Actuated Medical Inc: Actuated Medical Inc (Actuated Medical) is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems, and MRI-compatible systems. Its controlled tissue penetration systems use low force, electronically controlled motion to enable smooth insertion of sharps for serial blood sampling procedures. Actuated Medical’s also provides tube-clearing solutions that remove clogs in patients.

Multiparameter Patient Monitoring Pipeline Market Analysis by Companies, 2023

Multiparameter Patient Monitoring Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Multiparameter Patient Monitoring Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Multiparameter Patient Monitoring Pipeline Market Segments Outlook

  • Vital Sign Monitors
  • Ambulatory Monitors
  • Critical Care Monitors
  • Low Acuity Monitors

Multiparameter Patient Monitoring Pipeline Market Territories Outlook

  • The US
  • Europe
  • Israel
  • Canada
  • China

Multiparameter Patient Monitoring Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • ICAC
  • NMPA
  • MDL

Scope

This report provides:

  • Extensive coverage of the multiparameter patient monitoring under development.

  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.

  • Reviews of major players involved in the development of multiparameter patient monitoring and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of multiparameter patient monitoring under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

19Labs Inc
A*STAR Institute of Microelectronics
Aclaris Medical, LLC
Actuated Medical Inc
Advanced Medical Electronics Corp
Aerotel Medical Systems (1988) Ltd
Aevice Health Pte Ltd
Agatsa Software Pvt Ltd
Analog Devices Inc
AquilX Inc
ARC Devices Ltd.
Arizona State University
Atoptix LLC
Basil Leaf Technologies LLC
Baxter International Inc
Bertec Corp
Bhabha Atomic Research Centre
Binghamton University
BioNovus Technologies, LLC
BioSerenity SAS
Biovotion AG
Bips Health
BodyCap SAS
Boise State University
California Institute of Technology
CardieX Ltd
Cardiomo Care Inc
CareTaker Medical LLC
Celero Systems Inc
Clemson University
Cloud DX Inc.
Consano Medical Inc
Consortium Center for Biomedical Research Network
Cortrium ApS
CorTronix Biomedical Advancement Technologies Inc (Inactive)
Cyber Medical Ltd (Inactive)
Detectivio AB
DoseCue, LLC
EchoCare Technologies Ltd
Ecole Polytechnique Federale de Lausanne
Elfi-Tech Ltd.
Empirical Technologies Corporation
Epicore Biosystems Inc
Erasmus MC
Evolucare Group
Fabrixense
Facedrive Healthcare Inc
FIZE Medical Inc
Florida Atlantic University
Fraunhofer-Institut fur Integrierte Schaltungen
Fujitsu Ltd
G Medical Innovations Ltd
GE Global Research
GE HealthCare Technologies Inc
Georgia Institute of Technology
Great Lakes NeuroTechnologies Inc
H-Cubed Inc.
HeartSounds, Inc.
Hill-Rom Holdings Inc
Hope College Dining Services
Iceni Labs Ltd
Impact Instrumentation, Inc.
ImpediMed Ltd
Informed Data Systems Inc
Integrated Medical Sensors
Intisen Technology Pvt Ltd
IQ Biozoom Sp z oo
Johns Hopkins University
Kestrel Medical Ltd
KGPS Israel Ltd
Koronis Biomedical Technologies Corporation
Kyushu University
Leman Micro Devices SA
Lepu Medical Technology (Beijing) Co Ltd
Lionsgate Technologies Inc.
Massachusetts General Hospital
Massachusetts Institute of Technology
Medical Care Technologies, Inc.
Medieta Oy
Meditrace LLC
Monash University
Movano Inc
MS Westfalia GmbH
MX Labs
Nano Vision
National University of Singapore
Noninvasive Medical Technologies Inc
Norbert Health Inc
North Carolina State University
Northwestern University
Norwegian University of Science and Technology
Novartis AG
Oregon State University
Oxiwear
Pacific Northwest National Laboratory
Pennsylvania State University
Physical Activity Innovations, Inc. (Inactive)
PneumoSonics Inc.
Pressao Medical
Profusa Inc
Purdue University
Qualcomm Life Inc
Quanttus Inc
Quick, LLC
Ram Group DE GmbH
RDS SAS
REALTROMINS Inc
Recon Health Inc
Rekovar Inc
Rensselaer Polytechnic Institute
ResMed Inc
ResMed Ltd
Rhemisphere
RTM Vital Signs LLC
Samasti Health Technologies Pvt Ltd
Savemom Pvt Ltd
Scanadu Incorporated (Inactive)
Scanbo Technologies Inc
Sempulse
Senbiosys AG
Shenzhen Creative Industry Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Sky Labs Inc
Somno ART
Sonica Health
Sotera Wireless Inc
Speer Medical Devices Inc
Stanford University
Telebionix Inc.
The Chinese University of Hong Kong
The Feinstein Institute for Medical Research
The University of British Columbia
TheraNova LLC
Tranquility IOT and Big Data Solutions Pvt Ltd
TruVitals Inc
Tufts University
Umea University
University Medical Center Utrecht
University of Aberdeen
University of California Irvine
University of California Los Angeles
University of California San Diego
University of Florida
University of Glasgow
University of Hong Kong
University of Illinois
University of Memphis
University of Michigan
University of Michigan Pediatric Device Consortium
University of Missouri
University of North Carolina at Chapel Hill
University of Oxford
University of South Florida
University of Technology Sydney
University of Texas at Arlington
University of Texas at Austin
University of Tokyo
University of Washington
University of Waterloo
Venturi Ventures Inc (Inactive)
Vitalerter Ltd
VitalTracer Ltd
VitaScope
VivaLnk, Inc.
Vivonics Inc
VoluMetrix LLC
Wesper Inc
Worcester Polytechnic Institute
Xhale Inc
X-trodes Ltd

Table of Contents

1 Table of Contents 3

1.1 List of Tables 12

1.2 List of Figures 24

2 Introduction 25

2.1 Multiparameter Patient Monitoring Overview 25

3 Products under Development 27

3.1 Multiparameter Patient Monitoring – Pipeline Products by Stage of Development 27

3.2 Multiparameter Patient Monitoring – Pipeline Products by Segment 28

3.3 Multiparameter Patient Monitoring – Pipeline Products by Territory 29

3.4 Multiparameter Patient Monitoring – Pipeline Products by Regulatory Path 30

3.5 Multiparameter Patient Monitoring – Pipeline Products by Estimated Approval Date 31

3.6 Multiparameter Patient Monitoring – Ongoing Clinical Trials 32

4 Multiparameter Patient Monitoring – Pipeline Products under Development by Companies 33

4.1 Multiparameter Patient Monitoring Companies – Pipeline Products by Stage of Development 33

4.2 Multiparameter Patient Monitoring – Pipeline Products by Stage of Development 40

5 Multiparameter Patient Monitoring Companies and Product Overview 45

5.1 19Labs Inc Company Overview 45

5.1.1 19Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.2 A*STAR Institute of Microelectronics Company Overview 46

5.2.1 A*STAR Institute of Microelectronics Pipeline Products & Ongoing Clinical Trials Overview 46

5.3 Aclaris Medical, LLC Company Overview 48

5.3.1 Aclaris Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.4 Actuated Medical Inc Company Overview 49

5.4.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.5 Advanced Medical Electronics Corp Company Overview 50

5.5.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 50

5.6 Aerotel Medical Systems (1988) Ltd Company Overview 51

5.6.1 Aerotel Medical Systems (1988) Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.7 Aevice Health Pte Ltd Company Overview 52

5.7.1 Aevice Health Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.8 Agatsa Software Pvt Ltd Company Overview 56

5.8.1 Agatsa Software Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.9 Analog Devices Inc Company Overview 57

5.9.1 Analog Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.10 AquilX Inc Company Overview 58

5.10.1 AquilX Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.11 ARC Devices Ltd. Company Overview 59

5.11.1 ARC Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 59

5.12 Arizona State University Company Overview 61

5.12.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 61

5.13 Atoptix LLC Company Overview 62

5.13.1 Atoptix LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.14 Basil Leaf Technologies LLC Company Overview 63

5.14.1 Basil Leaf Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.15 Baxter International Inc Company Overview 64

5.15.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.16 Bertec Corp Company Overview 65

5.16.1 Bertec Corp Pipeline Products & Ongoing Clinical Trials Overview 65

5.17 Bhabha Atomic Research Centre Company Overview 66

5.17.1 Bhabha Atomic Research Centre Pipeline Products & Ongoing Clinical Trials Overview 66

5.18 Binghamton University Company Overview 67

5.18.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 67

5.19 BioNovus Technologies, LLC Company Overview 68

5.19.1 BioNovus Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

5.20 BioSerenity SAS Company Overview 69

5.20.1 BioSerenity SAS Pipeline Products & Ongoing Clinical Trials Overview 69

5.21 Biovotion AG Company Overview 72

5.21.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 72

5.22 Bips Health Company Overview 73

5.22.1 Bips Health Pipeline Products & Ongoing Clinical Trials Overview 73

5.23 BodyCap SAS Company Overview 74

5.23.1 BodyCap SAS Pipeline Products & Ongoing Clinical Trials Overview 74

5.24 Boise State University Company Overview 75

5.24.1 Boise State University Pipeline Products & Ongoing Clinical Trials Overview 75

5.25 California Institute of Technology Company Overview 76

5.25.1 California Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76

5.26 CardieX Ltd Company Overview 78

5.26.1 CardieX Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.27 Cardiomo Care Inc Company Overview 80

5.27.1 Cardiomo Care Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.28 CareTaker Medical LLC Company Overview 81

5.28.1 CareTaker Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.29 Celero Systems Inc Company Overview 86

5.29.1 Celero Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.30 Clemson University Company Overview 89

5.30.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 89

5.31 Cloud DX Inc. Company Overview 90

5.31.1 Cloud DX Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

5.32 Consano Medical Inc Company Overview 91

5.32.1 Consano Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.33 Consortium Center for Biomedical Research Network Company Overview 92

5.33.1 Consortium Center for Biomedical Research Network Pipeline Products & Ongoing Clinical Trials Overview 92

5.34 Cortrium ApS Company Overview 93

5.34.1 Cortrium ApS Pipeline Products & Ongoing Clinical Trials Overview 93

5.35 CorTronix Biomedical Advancement Technologies Inc (Inactive) Company Overview 94

5.35.1 CorTronix Biomedical Advancement Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 94

5.36 Cyber Medical Ltd (Inactive) Company Overview 95

5.36.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

5.37 Detectivio AB Company Overview 96

5.37.1 Detectivio AB Pipeline Products & Ongoing Clinical Trials Overview 96

5.38 DoseCue, LLC Company Overview 97

5.38.1 DoseCue, LLC Pipeline Products & Ongoing Clinical Trials Overview 97

5.39 EchoCare Technologies Ltd Company Overview 98

5.39.1 EchoCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.40 Ecole Polytechnique Federale de Lausanne Company Overview 99

5.40.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 99

5.41 Elfi-Tech Ltd. Company Overview 101

5.41.1 Elfi-Tech Ltd. Pipeline Products & Ongoing Clinical Trials Overview 101

5.42 Empirical Technologies Corporation Company Overview 102

5.42.1 Empirical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 102

5.43 Epicore Biosystems Inc Company Overview 103

5.43.1 Epicore Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.44 Erasmus MC Company Overview 104

5.44.1 Erasmus MC Pipeline Products & Ongoing Clinical Trials Overview 104

5.45 Evolucare Group Company Overview 105

5.45.1 Evolucare Group Pipeline Products & Ongoing Clinical Trials Overview 105

5.46 Fabrixense Company Overview 108

5.46.1 Fabrixense Pipeline Products & Ongoing Clinical Trials Overview 108

5.47 Facedrive Healthcare Inc Company Overview 109

5.47.1 Facedrive Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.48 FIZE Medical Inc Company Overview 111

5.48.1 FIZE Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 111

5.49 Florida Atlantic University Company Overview 112

5.49.1 Florida Atlantic University Pipeline Products & Ongoing Clinical Trials Overview 112

5.50 Fraunhofer-Institut fur Integrierte Schaltungen Company Overview 113

5.50.1 Fraunhofer-Institut fur Integrierte Schaltungen Pipeline Products & Ongoing Clinical Trials Overview 113

5.51 Fujitsu Ltd Company Overview 114

5.51.1 Fujitsu Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

5.52 G Medical Innovations Ltd Company Overview 115

5.52.1 G Medical Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

5.53 GE Global Research Company Overview 116

5.53.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 116

5.54 GE HealthCare Technologies Inc Company Overview 118

5.54.1 GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.55 Georgia Institute of Technology Company Overview 119

5.55.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 119

5.56 Great Lakes NeuroTechnologies Inc Company Overview 122

5.56.1 Great Lakes NeuroTechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.57 H-Cubed Inc. Company Overview 123

5.57.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 123

5.58 HeartSounds, Inc. Company Overview 124

5.58.1 HeartSounds, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124

5.59 Hill-Rom Holdings Inc Company Overview 125

5.59.1 Hill-Rom Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.60 Hope College Dining Services Company Overview 126

5.60.1 Hope College Dining Services Pipeline Products & Ongoing Clinical Trials Overview 126

5.61 Iceni Labs Ltd Company Overview 127

5.61.1 Iceni Labs Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.62 Impact Instrumentation, Inc. Company Overview 129

5.62.1 Impact Instrumentation, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129

5.63 ImpediMed Ltd Company Overview 130

5.63.1 ImpediMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.64 Informed Data Systems Inc Company Overview 133

5.64.1 Informed Data Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 133

5.65 Integrated Medical Sensors Company Overview 134

5.65.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 134

5.66 Intisen Technology Pvt Ltd Company Overview 135

5.66.1 Intisen Technology Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

5.67 IQ Biozoom Sp z oo Company Overview 136

5.67.1 IQ Biozoom Sp z oo Pipeline Products & Ongoing Clinical Trials Overview 136

5.68 Johns Hopkins University Company Overview 137

5.68.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 137

5.69 Kestrel Medical Ltd Company Overview 138

5.69.1 Kestrel Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 138

5.70 KGPS Israel Ltd Company Overview 139

5.70.1 KGPS Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 139

5.71 Koronis Biomedical Technologies Corporation Company Overview 140

5.71.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 140

5.72 Kyushu University Company Overview 141

5.72.1 Kyushu University Pipeline Products & Ongoing Clinical Trials Overview 141

5.73 Leman Micro Devices SA Company Overview 142

5.73.1 Leman Micro Devices SA Pipeline Products & Ongoing Clinical Trials Overview 142

5.74 Lepu Medical Technology (Beijing) Co Ltd Company Overview 143

5.74.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

5.75 Lionsgate Technologies Inc. Company Overview 145

5.75.1 Lionsgate Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 145

5.76 Massachusetts General Hospital Company Overview 146

5.76.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 146

5.77 Massachusetts Institute of Technology Company Overview 147

5.77.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 147

5.78 Medical Care Technologies, Inc. Company Overview 150

5.78.1 Medical Care Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150

5.79 Medieta Oy Company Overview 151

5.79.1 Medieta Oy Pipeline Products & Ongoing Clinical Trials Overview 151

5.80 Meditrace LLC Company Overview 152

5.80.1 Meditrace LLC Pipeline Products & Ongoing Clinical Trials Overview 152

5.81 Monash University Company Overview 153

5.81.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 153

5.82 Movano Inc Company Overview 154

5.82.1 Movano Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.83 MS Westfalia GmbH Company Overview 158

5.83.1 MS Westfalia GmbH Pipeline Products & Ongoing Clinical Trials Overview 158

5.84 MX Labs Company Overview 161

5.84.1 MX Labs Pipeline Products & Ongoing Clinical Trials Overview 161

5.85 Nano Vision Company Overview 165

5.85.1 Nano Vision Pipeline Products & Ongoing Clinical Trials Overview 165

5.86 National University of Singapore Company Overview 166

5.86.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 166

5.87 Noninvasive Medical Technologies Inc Company Overview 167

5.87.1 Noninvasive Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 167

5.88 Norbert Health Inc Company Overview 169

5.88.1 Norbert Health Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.89 North Carolina State University Company Overview 172

5.89.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 172

5.90 Northwestern University Company Overview 174

5.90.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 174

5.91 Norwegian University of Science and Technology Company Overview 175

5.91.1 Norwegian University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 175

5.92 Novartis AG Company Overview 176

5.92.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 176

5.93 Oregon State University Company Overview 178

5.93.1 Oregon State University Pipeline Products & Ongoing Clinical Trials Overview 178

5.94 Oxiwear Company Overview 179

5.94.1 Oxiwear Pipeline Products & Ongoing Clinical Trials Overview 179

5.95 Pacific Northwest National Laboratory Company Overview 180

5.95.1 Pacific Northwest National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 180

5.96 Pennsylvania State University Company Overview 181

5.96.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 181

5.97 Physical Activity Innovations, Inc. (Inactive) Company Overview 182

5.97.1 Physical Activity Innovations, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 182

5.98 PneumoSonics Inc. Company Overview 183

5.98.1 PneumoSonics Inc. Pipeline Products & Ongoing Clinical Trials Overview 183

5.99 Pressao Medical Company Overview 184

5.99.1 Pressao Medical Pipeline Products & Ongoing Clinical Trials Overview 184

5.100 Profusa Inc Company Overview 185

5.100.1 Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.101 Purdue University Company Overview 186

5.101.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 186

5.102 Qualcomm Life Inc Company Overview 187

5.102.1 Qualcomm Life Inc Pipeline Products & Ongoing Clinical Trials Overview 187

5.103 Quanttus Inc Company Overview 188

5.103.1 Quanttus Inc Pipeline Products & Ongoing Clinical Trials Overview 188

5.104 Quick, LLC Company Overview 189

5.104.1 Quick, LLC Pipeline Products & Ongoing Clinical Trials Overview 189

5.105 Ram Group DE GmbH Company Overview 190

5.105.1 Ram Group DE GmbH Pipeline Products & Ongoing Clinical Trials Overview 190

5.106 RDS SAS Company Overview 191

5.106.1 RDS SAS Pipeline Products & Ongoing Clinical Trials Overview 191

5.107 REALTROMINS Inc Company Overview 194

5.107.1 REALTROMINS Inc Pipeline Products & Ongoing Clinical Trials Overview 194

5.108 Recon Health Inc Company Overview 197

5.108.1 Recon Health Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.109 Rekovar Inc Company Overview 198

5.109.1 Rekovar Inc Pipeline Products & Ongoing Clinical Trials Overview 198

5.110 Rensselaer Polytechnic Institute Company Overview 199

5.110.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 199

5.111 ResMed Inc Company Overview 200

5.111.1 ResMed Inc Pipeline Products & Ongoing Clinical Trials Overview 200

5.112 ResMed Ltd Company Overview 204

5.112.1 ResMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 204

5.113 Rhemisphere Company Overview 205

5.113.1 Rhemisphere Pipeline Products & Ongoing Clinical Trials Overview 205

5.114 RTM Vital Signs LLC Company Overview 206

5.114.1 RTM Vital Signs LLC Pipeline Products & Ongoing Clinical Trials Overview 206

5.115 Samasti Health Technologies Pvt Ltd Company Overview 207

5.115.1 Samasti Health Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

5.116 Savemom Pvt Ltd Company Overview 208

5.116.1 Savemom Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 208

5.117 Scanadu Incorporated (Inactive) Company Overview 209

5.117.1 Scanadu Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 209

5.118 Scanbo Technologies Inc Company Overview 210

5.118.1 Scanbo Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 210

5.119 Sempulse Company Overview 212

5.119.1 Sempulse Pipeline Products & Ongoing Clinical Trials Overview 212

5.120 Senbiosys AG Company Overview 213

5.120.1 Senbiosys AG Pipeline Products & Ongoing Clinical Trials Overview 213

5.121 Shenzhen Creative Industry Co Ltd Company Overview 214

5.121.1 Shenzhen Creative Industry Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.122 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 216

5.122.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

5.123 Sky Labs Inc Company Overview 218

5.123.1 Sky Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 218

5.124 Somno ART Company Overview 221

5.124.1 Somno ART Pipeline Products & Ongoing Clinical Trials Overview 221

5.125 Sonica Health Company Overview 222

5.125.1 Sonica Health Pipeline Products & Ongoing Clinical Trials Overview 222

5.126 Sotera Wireless Inc Company Overview 225

5.126.1 Sotera Wireless Inc Pipeline Products & Ongoing Clinical Trials Overview 225

5.127 Speer Medical Devices Inc Company Overview 226

5.127.1 Speer Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.128 Stanford University Company Overview 227

5.128.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 227

5.129 Telebionix Inc. Company Overview 228

5.129.1 Telebionix Inc. Pipeline Products & Ongoing Clinical Trials Overview 228

5.130 The Chinese University of Hong Kong Company Overview 230

5.130.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 230

5.131 The Feinstein Institute for Medical Research Company Overview 233

5.131.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 233

5.132 The University of British Columbia Company Overview 234

5.132.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 234

5.133 TheraNova LLC Company Overview 235

5.133.1 TheraNova LLC Pipeline Products & Ongoing Clinical Trials Overview 235

5.134 Tranquility IOT and Big Data Solutions Pvt Ltd Company Overview 236

5.134.1 Tranquility IOT and Big Data Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 236

5.135 TruVitals Inc Company Overview 238

5.135.1 TruVitals Inc Pipeline Products & Ongoing Clinical Trials Overview 238

5.136 Tufts University Company Overview 239

5.136.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 239

5.137 Umea University Company Overview 240

5.137.1 Umea University Pipeline Products & Ongoing Clinical Trials Overview 240

5.138 University Medical Center Utrecht Company Overview 241

5.138.1 University Medical Center Utrecht Pipeline Products & Ongoing Clinical Trials Overview 241

5.139 University of Aberdeen Company Overview 242

5.139.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 242

5.140 University of California Irvine Company Overview 243

5.140.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 243

5.141 University of California Los Angeles Company Overview 244

5.141.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 244

5.142 University of California San Diego Company Overview 246

5.142.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 246

5.143 University of Florida Company Overview 251

5.143.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 251

5.144 University of Glasgow Company Overview 252

5.144.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 252

5.145 University of Hong Kong Company Overview 253

5.145.1 University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 253

5.146 University of Illinois Company Overview 254

5.146.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 254

5.147 University of Memphis Company Overview 255

5.147.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 255

5.148 University of Michigan Company Overview 256

5.148.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 256

5.149 University of Michigan Pediatric Device Consortium Company Overview 257

5.149.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 257

5.150 University of Missouri Company Overview 258

5.150.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 258

5.151 University of North Carolina at Chapel Hill Company Overview 259

5.151.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 259

5.152 University of Oxford Company Overview 263

5.152.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 263

5.153 University of South Florida Company Overview 264

5.153.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 264

5.154 University of Technology Sydney Company Overview 265

5.154.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 265

5.155 University of Texas at Arlington Company Overview 266

5.155.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 266

5.156 University of Texas at Austin Company Overview 267

5.156.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 267

5.157 University of Tokyo Company Overview 268

5.157.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 268

5.158 University of Washington Company Overview 269

5.158.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 269

5.159 University of Waterloo Company Overview 271

5.159.1 University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview 271

5.160 Venturi Ventures Inc (Inactive) Company Overview 272

5.160.1 Venturi Ventures Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 272

5.161 Vitalerter Ltd Company Overview 273

5.161.1 Vitalerter Ltd Pipeline Products & Ongoing Clinical Trials Overview 273

5.162 VitalTracer Ltd Company Overview 274

5.162.1 VitalTracer Ltd Pipeline Products & Ongoing Clinical Trials Overview 274

5.163 VitaScope Company Overview 279

5.163.1 VitaScope Pipeline Products & Ongoing Clinical Trials Overview 279

5.164 VivaLnk, Inc. Company Overview 280

5.164.1 VivaLnk, Inc. Pipeline Products & Ongoing Clinical Trials Overview 280

5.165 Vivonics Inc Company Overview 281

5.165.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 281

5.166 VoluMetrix LLC Company Overview 282

5.166.1 VoluMetrix LLC Pipeline Products & Ongoing Clinical Trials Overview 282

5.167 Wesper Inc Company Overview 283

5.167.1 Wesper Inc Pipeline Products & Ongoing Clinical Trials Overview 283

5.168 Worcester Polytechnic Institute Company Overview 284

5.168.1 Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 284

5.169 Xhale Inc Company Overview 285

5.169.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview 285

5.170 X-trodes Ltd Company Overview 286

5.170.1 X-trodes Ltd Pipeline Products & Ongoing Clinical Trials Overview 286

6 Multiparameter Patient Monitoring- Recent Developments 289

6.1 Nov 07, 2023: Masimo Announces New Member of the Board of Directors 289

6.2 Oct 31, 2023: Samsung Electronics Reports Q3 2023 Results 289

6.3 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 293

6.4 Oct 30, 2023: Panasonic Holdings Announces Financial Results for Six Months Ended September 30, 2023 295

6.5 Oct 26, 2023: ResMed Announces Results for the First Quarter of Fiscal Year 2024 295

6.6 Oct 26, 2023: Intel Reports Third-Quarter 2023 Financial Results 296

6.7 Oct 24, 2023: Danaher Reports Third Quarter 2023 Results 301

6.8 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023 302

6.9 Oct 13, 2023: Intricon Names Medical Device Veteran as New CFO 302

6.10 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 302

6.11 Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer 303

6.12 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors 303

6.13 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 303

6.14 Sep 05, 2023: ResMed Announces Participation in Upcoming Conferences 304

6.15 Aug 31, 2023: Danaher and Veralto to Webcast Investor and Analyst Meeting 304

6.16 Aug 29, 2023: Cloud DX Reports Results for the Second Quarter and First Six Months of 2023 305

6.17 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference 307

6.18 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 307

6.19 Aug 24, 2023: OSI Systems Posts Results for Q4 and Fiscal Year Ended June 30, 2023 307

6.20 Aug 22, 2023: Cloud DX Will Report Second Quarter and First Six Months 2023 Results and Hold Earnings Call on August 29, 2023 309

6.21 Aug 18, 2023: Intel Layoffs Impact GPU And Cloud Software Staff Among Wide Range of Roles 309

6.22 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion 309

6.23 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees 309

6.24 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 310

6.25 Aug 03, 2023: ResMed Announces Results for the Fourth Quarter of Fiscal Year 2023 310

6.26 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution 311

6.27 Jul 27, 2023: F. Hoffmann-La Roche Announces Half Year Results 2023 312

6.28 May 26, 2023: Observe Medical announces minutes from annual general meeting 312

6.29 May 17, 2023: Nihon Kohden announces consolidated financial results for the fiscal year ended March 31, 2023 312

6.30 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 312

6.31 May 09, 2023: Redsense Medical announces interim report Q1 January – March, 2023 313

6.32 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 314

6.33 May 08, 2023: Intel announces layoffs after paying $1.5 billion in Q1 dividends 315

6.34 May 05, 2023: Drager’s Annual General Meeting approves stable dividend for fiscal year 2022 315

6.35 May 02, 2023: ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer 316

6.36 May 02, 2023: OSI Systems receives $12 Million Order for Patient Monitoring Systems 316

6.37 Apr 28, 2023: Siemens to announce second quarter results FY 2023 317

6.38 Apr 27, 2023: OSI Systems announces fiscal 2023 Q3 financial results 317

6.39 Apr 27, 2023: ResMed announces results for the third quarter of fiscal year 2023 319

6.40 Apr 12, 2023: Medtronic has a layoff in California 321

6.41 Apr 06, 2023: ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023 321

6.42 Apr 05, 2023: Philips leads in medical technology patents filed at the European Patent Office 321

6.43 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format 322

6.44 Mar 21, 2023: Intel Appoints Stuart Pann to Lead Intel Foundry Services 322

6.45 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 323

6.46 Mar 03, 2023: Fiscal year 2021: Once Again, Drager Achieves Good Net Sales Development and Solid Earnings 323

6.47 Feb 23, 2023: Intel is laying off 112 more workers in Silicon Valley 324

6.48 Feb 22, 2023: Cloud DX Launches First Remote Monitoring Program for Type 2 Diabetes Patients 324

6.49 Feb 16, 2023: Samsung Electronics Announces 2022 Consolidated Financial Statements 325

6.50 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations 327

6.51 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results 327

6.52 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023 329

6.53 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023 330

6.54 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023 330

6.55 Feb 07, 2023: Cloud DX Clients Expand Contracts in Response to 50%–200% Growth in Remote Monitoring Programs 332

6.56 Feb 03, 2023: Moog Reports First Quarter 2023 Results With Sales Growth and Improving Margins 333

6.57 Feb 03, 2023: Panasonic Holdings Reports its Consolidated Financial Results for the Nine Months ended December 31, 2022 336

6.58 Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022 338

6.59 Feb 01, 2023: Canon posts record revenues in medical business unit 338

6.60 Jan 31, 2023: Fujitsu Announces New management structure, Executive Officers appointments and resignations 339

6.61 Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023 339

6.62 Jan 31, 2023: Fujitsu Announces FY 2022 Nine-Month Financial Results 341

6.63 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 341

6.64 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 341

6.65 Jan 30, 2023: Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease 344

6.66 Jan 30, 2023: Intel warns officials it plans 343 layoffs at its Folsom campus 344

6.67 Jan 27, 2023: Intel Reports Fourth-Quarter and Full-Year 2022 Financial Results 344

6.68 Jan 26, 2023: OSI Systems announces fiscal 2023 Q2 results 344

6.69 Jan 24, 2023: Intel Layoff Hundreds of Jobs 346

6.70 Jan 23, 2023: Intel hires Frank Yeary as independent chair 346

6.71 Jan 23, 2023: Intel Chairman Omar Ishrak steps down 347

6.72 Jan 20, 2023: Cloud DX Reports FY2022 Results 347

6.73 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 348

6.74 Jan 17, 2023: Dragerwerk AG Announces Preliminary net sales and earnings figures 2022 348

6.75 Jan 16, 2023: Samsung hires ex-Yogiyo CEO to lead online sales as rivals axe jobs 349

6.76 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 349

6.77 Dec 30, 2022: Samsung Appoints Hubert H. Lee To Lead Its MX Design Team 350

6.78 Dec 18, 2022: Intel Israel lays off dozens amid ongoing hi-tech firing wave 351

6.79 Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche’s new CEO 351

6.80 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 351

6.81 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 352

6.82 Dec 06, 2022: Intel to lay off hundreds of employees 352

6.83 Nov 30, 2022: Fujitsu Interim Report On First-Half FY 2022 Financial Results 353

6.84 Nov 23, 2022: Medtronic Reports Quarterly Earnings 353

6.85 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 353

6.86 Nov 22, 2022: Intel appoints Barbara Novick to board of directors 359

6.87 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 359

7 Appendix 360

7.1 Methodology 360

7.2 About GlobalData 363

7.3 Contact Us 363

7.4 Disclaimer 363

Frequently asked questions

Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Multiparameter Patient Monitoring reports
Medical Devices
New
Clinical Chemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | November 2023
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | November 2023
Medical Devices
United States Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | March 2019
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more